https://tonic.inserm.fr/wp-content/uploads/2019/06/equipe-homme-defaut-150x150.jpg
 

Nicolas DELCOURT

(MCU-PA)

    Publications rédigées ou co-rédigées

  • > 31- Cellular and Molecular Aspects of the β-N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy.

    Delcourt N, Claudepierre T, Maignien T, Arnich N, Mattei C.

    Toxins (Basel). 2017 Dec 22;10(1). pii: E6. doi: 10.3390/toxins10010006. Review.
  • > 38- Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study).

    Yrondi A, Aouizerate B, El-Hage W, Moliere F, Thalamas C, Delcourt N, Sporer M, Taib S, Schmitt L, Arlicot N, Meligne D, Sommet A, Salabert AS, Guillaume S, Courtet P, Galtier F, Mariano-Goulart D, Champfleur NM, Bars EL, Desmidt T, Lemaire M, Camus V, Santiago-Ribeiro MJ, Cottier JP, Fernandez P, Meyer M, Dousset V, Doumy O, Delhaye D, Capuron L, Leboyer M, Haffen E, Péran P, Payoux P, Arbus C.

    Front Psychiatry. 2018 Jul 24;9:326. doi: 10.3389/fpsyt.2018.00326. eCollection 2018.
  • > 67- Cellular and Molecular Aspects of the β-N-Methylamino-l-alanine (BMAA) Mode of Action within the Neurodegenerative Pathway: Facts and Controversy.

    Delcourt N, Claudepierre T, Maignien T, Arnich N, Mattei C.

    Toxins (Basel). 2017 Dec 22;10(1). pii: E6. doi: 10.3390/toxins10010006. Review.